Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.33 USD | +0.38% | +7.68% | -21.27% |
06-03 | UniQure Shares Rise After US FDA Grants Regenerative Medicine Advanced Designation for Huntington's Treatment | MT |
06-03 | UniQure's AMT-130 Gets FDA RMAT Designation in Huntington's Disease | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.27% | 258M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- UniQure's Partner CSL Gets European Commission Approval for Hemgenix to Treat Hemophilia B